Abiopharma

Geraghty Michael C 🔴 sold 20.9K shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) at $90.02 Transaction Date: Dec 08, 2025 | Filing ID: 000016

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

FMR LLC 🔴 sold 4.7M shares (11 derivative) of Structure Therapeutics Inc. (GPCR) Transaction Date: Dec 08, 2025 | Filing ID: 313977

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

Fischer Laurent 🟡 adjusted position in 1.3M shares (11 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $10.14 ($9.1M) Transaction Date: Dec 09, 2025 | Filing ID: 000006

Soparkar Peter 🟡 adjusted position in 480.8K shares (10 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $10.14 ($3.1M) Transaction Date: Dec 09, 2025 | Filing ID: 000006

Ozden Rabia Gurses 🟡 adjusted position in 197.9K shares (5 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $10.14 ($1.3M) Transaction Date: Dec 09, 2025 | Filing ID: 000005

Seyedkazemi Setareh 🟡 adjusted position in 274.5K shares (6 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $10.14 ($1.6M) Transaction Date: Dec 09, 2025 | Filing ID: 000005

Rubinstein Linda M 🟡 adjusted position in 251.4K shares (4 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $10.14 ($2.1M) Transaction Date: Dec 09, 2025 | Filing ID: 000005

Hong Soo 🔴 sold 33.0K shares (4 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $15.60 Transaction Date: Dec 09, 2025 | Filing ID: 000005

Whitcup Scott M 🔴 sold 42.0K shares (7 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $256.40 ($1.8M) Transaction Date: Dec 09, 2025 | Filing ID: 000005

Tuckson Reed Vaughn 🔴 sold 33.5K shares (5 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $128.50 Transaction Date: Dec 09, 2025 | Filing ID: 000005

Svoronos Dawn 🔴 sold 42.5K shares (6 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $128.20 Transaction Date: Dec 09, 2025 | Filing ID: 000004

Scopa James Paul 🔴 sold 55.5K shares (8 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $256.40 ($2.0M) Transaction Date: Dec 09, 2025 | Filing ID: 000004

Nicholson, C. David 🔴 sold 29.0K shares (3 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $9.31 Transaction Date: Dec 09, 2025 | Filing ID: 000003